(Q40873616)

24 September 2017

title

Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus (English)

1 reference

24 September 2017

0 references

0 references

1 reference

Kochi S

1

1 reference

24 September 2017

Takanaga H

2

1 reference

24 September 2017

Matsuo H

3

1 reference

24 September 2017

Ohtani H

4

1 reference

24 September 2017

Naito M

5

1 reference

24 September 2017

Tsuruo T

6

1 reference

24 September 2017

Sawada Y

7

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

66

1 reference

24 September 2017

issue

23

1 reference

24 September 2017

page(s)

2255-2260

1 reference

Immunosuppressive therapy

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

FK506 augments activation-induced programmed cell death of T lymphocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Induction of apoptosis in mouse thymocytes by cyclosporin A: in vivo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

A reversible posterior leukoencephalopathy syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Apoptosis. Its significance in cancer and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Apoptosis in the pathogenesis and treatment of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Cyclosporine plasma unbound fraction in heart and lung transplantation recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Plasma protein binding of tacrolimus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2800%2900554-3

10.1016/S0024-3205(00)00554-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference